Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma

被引：0
|
作者：
Wang, Han [1 ]
Yu, Hua [1 ]
Qian, You-Wen [1 ]
Cao, Zhen-Ying [1 ]
Wu, Meng-Chao [2 ]
Cong, Wen-Ming [1 ]
机构：
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Pathol, Shanghai 200438, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai 200438, Peoples R China
来源：
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL | 2021年 / 20卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Postoperative transcatheter arterial; chemoembolization; Recurrence; Prognosis; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC RESECTION; EFFICACY; HEPATECTOMY; CM; OUTCOMES; IMPACT;
D O I：
10.1016/j.hbpd.2020.12.0181499-3872/
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Background: Surgical resection of huge hepatocellular carcinoma (HCC, 0.001) but not late recurrence ( 2 years, crude cohort: P = 0.692, PSM cohort: P = 0.325). Multivariable Cox regression analysis suggested that PA-TACE was an independent protective factor prolonging early RFS, RFS and OS. Conclusions: PA-TACE is a safe intervention for huge HCC patients after liver resection and improves outcomes. (c) 2021 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：232 / 239
页数：8
相关论文
共 50 条
  • [31] Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization
    Acunas, B
    Rozanes, I
    EUROPEAN JOURNAL OF RADIOLOGY, 1999, 32 (01) : 86 - 89
  • [32] DEXAMETHASONE IMPROVES CLINICAL AND BIOCHEMICAL TOLERANCE OF TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Masrour, Oumnia
    Giguet, Baptiste
    Rayer, Cassandra
    Uguen, Thomas
    Houssel-Debry, Pauline
    Jezequel, Caroline
    Jegonday, Marc-Antoine
    Quehen, Emmanuel
    Brun, Vanessa
    Moirand, Romain
    Jacquet, Edouard Bardou
    HEPATOLOGY, 2021, 74 : 632A - 633A
  • [33] Prognostic Significance of Tumor Growth Rate (TGR) in Patients with Huge Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization
    Chen, Guobin
    Xie, Xiaoying
    Wang, Meixia
    Guo, Xinkun
    Zhang, Zhenzhen
    Zhang, Lan
    Zhang, Boheng
    CURRENT ONCOLOGY, 2022, 29 (02) : 423 - 432
  • [34] TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA
    YANG, CF
    HO, YJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 : S86 - S88
  • [35] ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
    Mao, Jiaren
    Tan, Zhongjun
    Pan, Xiaoqi
    Meng, Feijian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [36] Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma
    Guo, Yuan
    Li, Ru-Chun
    Xia, Wei-Li
    Yang, Xiong
    Zhu, Wen-Bo
    Li, Fang-Ting
    Hu, Hong-Tao
    Li, Hai-Liang
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (07)
  • [37] Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction
    Kaibori, Masaki
    Tanigawa, Noboru
    Matsui, Yoichi
    Saito, Takamichi
    Uchida, Yoichiro
    Ishizaki, Morihiko
    Tanaka, Hironori
    Kamiyama, Yasuo
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3685 - 3692
  • [38] Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization
    Ikeda, Masafumi
    Mitsunaga, Shuichi
    Shimizu, Satoshi
    Ohno, Izumi
    Takahashi, Hideaki
    Okuyama, Hiroyuki
    Kuwahara, Akiko
    Kondo, Shunsuke
    Morizane, Chigusa
    Ueno, Hideki
    Satake, Mitsuo
    Arai, Yasuaki
    Okusaka, Takuji
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (05) : 932 - 940
  • [39] Carboplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
    Yamashita, F
    Tanaka, M
    Andou, E
    Yutani, S
    Kato, O
    Tanikawa, K
    ONCOLOGY, 1997, 54 (01) : 28 - 33
  • [40] Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization
    Masafumi Ikeda
    Shuichi Mitsunaga
    Satoshi Shimizu
    Izumi Ohno
    Hideaki Takahashi
    Hiroyuki Okuyama
    Akiko Kuwahara
    Shunsuke Kondo
    Chigusa Morizane
    Hideki Ueno
    Mitsuo Satake
    Yasuaki Arai
    Takuji Okusaka
    Journal of Gastroenterology, 2014, 49 : 932 - 940
12345